Ochsner Health COVID-19 SharePoint Site "Safety On Site" Click here to enter an S.O.S.
Medications listed are available on OH EPIC Formulary, unless otherwise noted.
Not all formulary medications are available at each facility. Please refer to your local pharmacy for available inventory.
Search results for:

nivolumab-relatlimab

nivolumab-relatlimab
Drug Name Form Strength Infusion Center Available Restricted Non-formulary Ambulatory Available Interchange REMS
Opdualag SOLUTION, INTRAVENOUS rmbw 240 mg-80 mg/20 mL        

VIEW MORE Antineoplastic Agents
CLASS
100000

Additional Information and Links
  • Service line: Hematology/Oncology
  • Formulary location: Outpatient infusion
  • Service location: Outpatient infusion center
  • Patient population: Adult, pediatrics 12 years or older
  • Prior authorization Required: Yes
  • Restriction/Criteria of use:
    • Diagnosis of Stage III (unresectable) or Stage IV metastatic melanoma
    • No active brain metastases or leptomeningeal metastases
    • No diagnosis of uveal melanoma
    • No active, known, or suspected autoimmune disease
    • Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
    • No prior systemic therapy in the unresectable or metastatic setting including chemotherapy, immunotherapy, or targeted therapy          

Last updated: Aug. 25, 2022
  • HazD: Under review


This site is intended for the staff of Ochsner Health. While others may view accessible pages, Ochsner Health makes no warranty, express or implied, as to the use of this information outside of Ochsner Health.